Chemoinformaics analysis of 1,8-dihydroxy-3,5-dimethoxy-xanthone
| Molecular Weight | 288.255 | nRot | 2 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 17 |
| Exact Molecular Weight | 288.063 | nRing | 3 |
| Solubility: LogS | -3.732 | nHRing | 1 |
| Solubility: LogP | 3.034 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 37.8635 |
| nHD | 2 | BPOL | 18.1145 |
| QED | 0.704 |
| Synth | 2.353 |
| Natural Product Likeliness | 1.382 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.062 |
| Pgp-sub | 0.005 |
| HIA | 0.031 |
| CACO-2 | -4.896 |
| MDCK | 0.000015 |
| BBB | 0.01 |
| PPB | 0.873502 |
| VDSS | 0.959 |
| FU | 0.141791 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.964 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.107 |
| CYP2c9-inh | 0.67 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.589 |
| CYP2d6-sub | 0.874 |
| CYP3a4-inh | 0.311 |
| CYP3a4-sub | 0.169 |
| CL | 5.548 |
| T12 | 0.652 |
| hERG | 0.006 |
| Ames | 0.715 |
| ROA | 0.211 |
| SkinSen | 0.647 |
| Carcinogencity | 0.11 |
| EI | 0.903 |
| Respiratory | 0.406 |
| NR-Aromatase | 0.826 |
| Antiviral | Yes |
| Prediction | 0.689321 |